ABSTRACT
SARS-CoV-2 infection has so far affected over 42 million people worldwide, causing over 1.1 million deaths. With the large majority of SARS-CoV-2 infected individuals being asymptomatic, major concerns have been raised about possible long-term consequences of the infection. We developed an antigen capture assay to detect SARS-CoV-2 spike protein in urine samples from COVID-19 patients whose diagnosis was confirmed by PCR from nasopharyngeal swabs (NP-PCR+). The study used a collection of 233 urine samples from 132 participants from Yale New Haven Hospital and the Children’s Hospital of Philadelphia obtained during the pandemic (106 NP-PCR+ and 26 NP-PCR-) as well as a collection of 20 urine samples from 20 individuals collected before the pandemic. Our analysis identified 23 out of 91 (25%) NP-PCR+ adult participants with SARS-CoV-2 spike S1 protein in urine (Ur-S+). Interestingly, although all NP-PCR+ children were Ur-S-, 1 NP-PCR-child was found to be positive for spike protein in urine. Of the 23 Ur-S+ adults, only 1 individual showed detectable viral RNA in urine. Our analysis further showed that 24% and 21% of NP-PCR+ adults have high levels of albumin and cystatin C in urine, respectively. Among individuals with albuminuria (>0.3 mg/mg of creatinine) statistical correlation could be found between albumin and spike protein in urine. Together, our data showe that 1 of 4 of SARS-CoV-2 infected individuals develop renal abnormalities such as albuminuria. Awareness about the long-term impact of these findings is warranted.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
CBM research is supported by grants from National Institute of Health (NIH) and the Steven and Alexandra Cohen Foundation. ARJ is an Investigator in the Pathogenesis of Infectious Diseases of the Burroughs Wellcome Fund, whose work is supported by NIH/NIAID R01AI103280, R21AI144472, and R21AI154370. JMT research was supported by NIH awards (K23HL114868, L30HL115790, R01HL139629, R21HL143092, R01HL128973, R01HL148354). IMPACT received support from the Yale COVID-19 Research Resource Fund. The authors declare no competing financial interests.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was approved by Yale Human Research Protection Program Institutional Review Boards (FWA00002571 protocol ID 2000027690). Urine collection from COVID-19 positive and negative children was conducted under protocol IRB20-017503 approved by the Institutional Review Board at Childrens Hospital of Philadelphia (FWA00000459). Informed consent was obtained from all enrolled participants. The pre-COVID-19 urine samples, from Kidney Biopsy participants were provided by Yale BioBank and the study was approved by Yale Human Investigation Committee (number 11110009286). The pre-COVID-19 urine samples from Heart Failure Cohort and healthy individuals were provided by JMT (HIC 1311013065).
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Data available upon request.
Abbreviations
- NP
- Nasopharyngeal
- ELISA
- Enzyme Linked Immunosorbent Assay
- HCoV
- Human Coronavirus
- KB
- Kidney Biopsy
- AKI
- Acute Kidney Infection
- UELISA
- Urine Capture ELISA
- FENa
- Fractional Excretion of Sodium
- FEUrea
- Fractional excretion of Urea
- Ur-S+
- Urine Spike positive
- Ur-S-
- Urine Spike negative
